Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23:275–94.
Google Scholar
Ali ES, Ben-Sahra I. Regulation of nucleotide metabolism in cancers and immune disorders. Trends Cell Biol. 2023;33:950–66.
Google Scholar
Chen J, Yang S, Li Y, Ziwen X, Zhang P, Song Q, et al. De novo nucleotide biosynthetic pathway and cancer. Genes Dis. 2023;10:2331–8.
Google Scholar
Gan B. The pyrimidinosome: orchestrating pyrimidine biosynthesis and ferroptosis defense. Mol Cell. 2023;83:2837–9.
Google Scholar
Dodson M, Zhang DD. The pyrimidinosome is cancer’s Achilles’ heel. Nat Cell Biol. 2023;25:798–9.
Google Scholar
Yang C, Zhao Y, Wang L, Guo Z, Ma L, Yang R, et al. De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence. Nat Cell Biol. 2023;25:836–47.
Google Scholar
Deng Y, Wang ZV, Gordillo R, An Y, Zhang C, Liang Q, et al. An adipo-biliary-uridine axis that regulates energy homeostasis. Science. 2017; 355.
Hanssen R, Rigoux L, Albus K, Kretschmer AC, Edwin Thanarajah S, Chen W, et al. Circulating uridine dynamically and adaptively regulates food intake in humans. Cell Rep Med. 2023;4:100897.
Google Scholar
Zhang Y, Guo S, Xie C, Fang J. Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis. Biomed Res Int. 2020;2020:7091718.
Google Scholar
Sykes DB, Kfoury YS, Mercier FE, Wawer MJ, Law JM, Haynes MK, et al. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. Cell. 2016;167:171–186 e15.
Google Scholar
Li L, Ng SR, Colon CI, Drapkin BJ, Hsu PP, Li Z, et al. Identification of DHODH as a therapeutic target in small cell lung cancer. Sci Transl Med. 2019; 11.
Wang X, Yang K, Wu Q, Kim LJY, Morton AR, Gimple RC, et al. Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells. Sci Transl Med. 2019; 11.
Elgamal OA, Fobare S, Vibhute S, Mehmood A, Vroom DC, Johnson ML, et al. Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia. JCI Insight. 2024; 9.
Evans DR, Guy HI. Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J Biol Chem. 2004;279:33035–8.
Google Scholar
Ma J, Zhao J, Zhang C, Tan J, Cheng A, Niu Z, et al. Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy. Nat Commun. 2025;16:5006.
Google Scholar
Graves LM, Guy HI, Kozlowski P, Huang M, Lazarowski E, Pope RM, et al. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature. 2000;403:328–32.
Google Scholar
Eberhardy SR, Farnham PJ. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem. 2001;276:48562–71.
Google Scholar
Huang M, Kozlowski P, Collins M, Wang Y, Haystead TA, Graves LM. Caspase-dependent cleavage of carbamoyl phosphate synthetase II during apoptosis. Mol Pharm. 2002;61:569–77.
Google Scholar
Li G, Li D, Wang T, He S. Pyrimidine biosynthetic enzyme CAD: its function, regulation, and diagnostic potential. Int J Mol Sci. 2021; 22.
Sahu U, Ben-Sahra I. The cell cycle loops UTP around CAD. Nat Metab. 2023;5:199–200.
Google Scholar
Shin J, Mir H, Khurram MA, Fujihara KM, Dynlacht BD, Cardozo TJ, et al. Allosteric regulation of CAD modulates de novo pyrimidine synthesis during the cell cycle. Nat Metab. 2023;5:277–93.
Google Scholar
Sahay N, Guy HI, Liu X, Evans DR. Regulation of an Escherichia coli/mammalian chimeric carbamoyl-phosphate synthetase. J Biol Chem. 1998;273:31195–202.
Google Scholar
Carrey EA, Campbell DG, Hardie DG. Phosphorylation and activation of hamster carbamyl phosphate synthetase II by cAMP-dependent protein kinase. A novel mechanism for regulation of pyrimidine nucleotide biosynthesis. EMBO J. 1985;4:3735–42.
Google Scholar
Sigoillot FD, Berkowski JA, Sigoillot SM, Kotsis DH, Guy HI. Cell cycle-dependent regulation of pyrimidine biosynthesis. J Biol Chem. 2003;278:3403–9.
Google Scholar
Robitaille AM, Christen S, Shimobayashi M, Cornu M, Fava LL, Moes S, et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science. 2013;339:1320–3.
Google Scholar
Kwon YT, Ciechanover A. The ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem Sci. 2017;42:873–86.
Google Scholar
Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818–22.
Google Scholar
Tsai JM, Nowak RP, Ebert BL, Fischer ES. Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol. 2024;25:740–57.
Google Scholar
Snyder NA, Silva GM. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response. J Biol Chem. 2021;297:101077.
Google Scholar
Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol Cell. 2022;82:15–29.
Google Scholar
Clague MJ, Urbe S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20:338–52.
Google Scholar
Xie X, Zhang B, Peng J, Ma N, Pan Q, Wei Y, et al. EGF-upregulated lncRNA ESSENCE promotes colorectal cancer growth through stabilizing CAD and ferroptosis defense. Research. 2025;8:0649.
Google Scholar
Li G, Xiao K, Li Y, Gao J, He S, Li T. CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells. Cell Oncol. 2024;47:851–65.
Google Scholar
Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23:842–62.
Google Scholar
Ren J, Yu P, Liu S, Li R, Niu X, Chen Y, et al. Deubiquitylating enzymes in cancer and immunity. Adv Sci. 2023;10:e2303807.
Google Scholar
Peng Y, Liu J, Wang Z, Cui C, Zhang T, Zhang S, et al. Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc. Cell Death Differ. 2022;29:1730–43.
Google Scholar
Zhao Y, Huang X, Zhu D, Wei M, Luo J, Yu S, et al. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. Cell Death Differ. 2022;29:2531–44.
Google Scholar
Liu X, Fang Y, Lv X, Hu C, Chen G, Zhang L, et al. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death Differ. 2023;30:1457–71.
Google Scholar
